• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Animal & Veterinary

  • Print
  • Share
  • E-mail

International Veterinary Drug Activities Engage FDA/CVM Scientists

by Pamela L. Chamberlain D.V.M., DABT, Ph.D.
FDA Veterinarian Newsletter March/April 2003 Volume XVIII, No 2

Veterinary Drug Residues and the Global Food Supply, Bangkok, Thailand

The National Food Processors Association (NFPA) invited the FDA/CVM to participate in a day-long seminar entitled, “Veterinary Drug Residues and the Global Food Supply” held in Bangkok, Thailand on January 23, 2003. The seminar was part of the NFPAs formal launch activities commemorating the opening of the organization’s first international regional office in Bangkok.

Some countries within this region are currently experiencing significant trade difficulties resulting from residues of chloramphenicol in certain exported seafood products. The seminar was designed to address, in a very comprehensive way, veterinary drug development, regulation, residue measurement and monitoring and appropriate use practices. NFPA-Asia will serve the food processors of Southeast Asia. The organization views this region as a key region for current and future food trade. The countries within southeast Asia that NFPA will be focusing on are Thailand, Indonesia, Malaysia, the Philippines, Singapore, Brunei, Vietnam, Laos, Myanmar, and Cambodia and to the extent possible, South Korea, and Japan. For now, their main focus is on Thailand.

Dr. Pamela Chamberlain represented the Center and gave presentations entitled, “Old Veterinary Drugs: Why do Problems Exist,” and “Residues in Foods: What are the Limits and Why?” The presentations were designed to deliver a clear message about the rigorous nature of the drug approval process in the U.S. and how tolerances, maximum residue limits and decisions to ban extra-label use of certain drugs are based on sound, scientific principles with protection of the public health being a primary concern. They are not arbitrary decisions designed to serve as barriers to trade.

The seminar was attended by approximately 150 people. Hallway feedback was very positive and complimentary toward all topics and presenters.

The NFPA was grateful for FDA/CVM’s participation because it provided an example to the future members of NFPA-Asia of the positive working relationship the organization has with government regulators in the United States.